Cargando…
Study comparing the efficacy and renal safety for patients with diabetes switching from dapagliflozin to empagliflozin
Background Previously, dapagliflozin was limited to patients with an estimated glomerular filtration rate (eGFR) ≥ 60 mL/min/1.73 m(2), while empagliflozin can be used for those with an eGFR ≥ 45 mL/min/1.73 m(2). Therefore dapagliflozin was switched to empagliflozin in many patients when eGFR decre...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352843/ https://www.ncbi.nlm.nih.gov/pubmed/33258006 http://dx.doi.org/10.1007/s11096-020-01210-1 |